Doctors record higher blood pressures than nurses: Systematic review and meta-analysis

British Journal of General Practice

Volumn 64, Issue 621, 2014, Pages

  Clark, Christopher E ^a   Horvath, Isabella A ^a   Taylor, Rod S ^a   Campbell, John L ^a  

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

Blood pressure determination; Primary health care; White coat hypertension; White coat syndrome

Indexed keywords

ARTICLE; BLOOD PRESSURE MEASUREMENT; DIASTOLIC BLOOD PRESSURE; HUMAN; MEAN ARTERIAL PRESSURE; META ANALYSIS; NURSE; PHYSICIAN; PRIMARY HEALTH CARE; SECONDARY HEALTH CARE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION; ADULT; BLOOD PRESSURE; EVIDENCE BASED MEDICINE; PATIENT REFERRAL; PROCEDURES; PSYCHOLOGY;

ADULT; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; EVIDENCE-BASED MEDICINE; HUMANS; NURSES; PHYSICIANS; REFERRAL AND CONSULTATION; WHITE COAT HYPERTENSION;

EID: 84898763737     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp14X677851     Document Type: Article

References (69)

1. Myers MG, Reeves RA. White coat phenomenon in patients receiving antihypertensive therapy. Am J Hypertens 1991; 4(10 Pt 1): 844-849.
2. Mancia G, Parati G, Pomidossi G, et al. Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension 1987; 9(2): 209-215.
3. Mancia G, Grassi G, Pomidossi G, et al. Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet 1983; 322(8352): 695-698.
4. Pickering TG, Gerin W, Schwartz AR. What is the white-coat effect and how should it be measured? Blood Press Monit 2002; 7(6): 293-300.
5. Pickering TG, Coats A, Mallion JM, et al. Task Force V: White-coat hypertension. Blood-Press-Monit 1999; 4(6).
6. Alves LM, Nogueira MS, Veiga EV, de GS, Carnio EC. White coat hypertension and nursing care. Can J Cardiovasc Nurs 2003; 13(3): 29-34.
7. Dolan E, Stanton A, Atkins N, et al. Determinants of white-coat hypertension...Proceedings from the 'European Society of Hypertension Working Group on Blood Pressure Monitoring Scientific Workshop: What's New in Blood Pressure Measurement?'; held June 2004 in Paris, France. Blood-Press-Monit 2004; 9(6): 307-310.
8. Strandberg TE, Salomaa V. White coat effect, blood pressure and mortality in men: prospective cohort study. Eur Heart J 2000; 21(20): 1714-1718.
9. Dawes MG, Bartlett G, Coats AJ, Juszczak E. Comparing the effects of white coat hypertension and sustained hypertension on mortality in a UK primary care setting. Ann Fam Med 2008; 6(5): 390-396.
10. Imai Y. Prognostic significance of ambulatory blood pressure. Blood Press Monit 1999; 4(5): 249-256.
11. Glynn LG, Murphy AW, Smith SM, et al. Interventions used to improve control of blood pressure in patients with hypertension. In: Cochrane Collaboration. The Cochrane Library. Issue 3. Oxford: Update Software, 2010.
12. Clark CE, Smith LFP, Taylor RS, Campbell JL. Nurse led interventions to improve control of blood pressure in people with hypertension: systematic review and meta-analysis. BMJ 2010; 341(aug23-1): c3995.
13. Clark CE, Smith LFP, Taylor RS, Campbell JL. Nurse led interventions to improve control of high blood pressure in people with diabetes: a systematic review and meta-analysis. Diabet Med 2011; 28(3): 250-261.
14. Clark CE, Smith LFP, Harding G, et al. Nurse led hypertension clinics: evolving ahead of the evidence? J Hum Hypertens 2011; 25 (S1)(10): S6.
15. Laurant M, Reeves D, Hermens R, et al. Substitution of doctors by nurses in primary care. In: Cochrane Collaboration. The Cochrane Library. Issue 4. Oxford: Update Software, 2004.
16. Graves JW, Sheps SG. Does evidence-based medicine suggest that physicians should not be measuring blood pressure in the hypertensive patient? Am J Hypertens 2004; 17(4): 354-360.
17. Lovibond K, Jowett S, Barton P, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet 2011; 378(9798): 1219-1230.
18. Clark CE, Smith LFP, Glynn LG, et al. Allied health professional-led interventions for improving control of blood pressure in patients with hypertension [Protocol]. Cochrane Database Syst Rev 2011; 11: CD009410. DOI: 10.1002/14651858.CD009410.
19. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283(15): 2008-2012.
20. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. In: Cochrane Collaboration. The Cochrane Library. Issue 5.1.0. Oxford: Update Software, 2011
21. Rao JN, Scott AJ. A simple method for the analysis of clustered binary data. Biometrics 1992; 48(2): 577-585.
22. Chapman JM, Clark VA, Coulson AH, Browning GG. Problems of measurement in blood pressure surveys: inter-observer differences in blood pressure determinations. Am J Epidemiol 1966; 84(3): 483-494.
23. Sterne JAC, Sutton AJ, Ioannidis JPA, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011; 343.
24. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315(7109): 629-634.
25. Kumpusalo E, Teho A, Laitila R, Takala J. Janus faces of the white coat effect: blood pressure not only rises, it may also fall. J Hum Hypertens 2002; 16(10): 725-728.
26. Labinson PT, Giacco S, Gift H, et al. The importance of the clinical observer in the development of a white-coat effect in African-American patients with hypertension. Blood Press Monit 2008; 13(3): 139-142.
27. Veerman DP, van Montfrans GA. Nurse-measured or ambulatory blood pressure in routine hypertension care. J Hypertens 1993; 11(3): 287-292.
28. Gil V, Martinez JL, Lopez N, et al. [Influence of the place of measurement and of the person who performs it on the control and diagnosis of arterial hypertension] Influencia del lugar de la toma y de quien la realiza en el control y diagnostico de la HTA. Rev Clin Esp 1994; 194(3): 152-156.
29. Culleton BF, McKay DW, Campbell NR. Performance of the automated BpTRU measurement device in the assessment of white-coat hypertension and white-coat effect. Blood Press Monit 2006; 11(1): 37-42.
30. de Blok K, Veerman DP, Hoek F, et al. Relationship between blood pressure, as measured by a nurse, by a doctor and under basal conditions, and micro-albuminuria and left ventricular mass. J Hypertens Suppl 1991; 9(6): S106-S107.
31. Gerin W, Marion RM, Friedman R, et al. How should we measure blood pressure in the doctor's office? Blood Press Monit 2001; 6(5): 257-262.
32. La Batide-Alanore A, Chatellier G, Bobrie G, et al. Comparison of nurse- and physician-determined clinic blood pressure levels in patients referred to a hypertension clinic: implications for subsequent management. J Hypertens 2000; 18(4): 391-398.
33. Mansoor GA, McCabe EJ, White WB. Determinants of the white-coat effect in hypertensive subjects. J Hum Hypertens 1996; 10(2): 87-92.
34. Yoon HJ, Ahn Y, Park JB, et al. Are metabolic risk factors and target organ damage more frequent in masked hypertension than in white coat hypertension? Clin Exp Hypertens 2010; 32(7): 480-485.
35. Salvador M, Chamontin B, Begasse F, Guittard J. [Outcome of 'white coat reaction' induced by nurse and physician in patients with hypertension treated with a beta blockader (bisoprolol)] Devenir sous beta-bloquant (bisoprolol), de l'effet 'blouse blanche' induit chez l'hypertendu par l'infirmiere et le medecin. Arch Mal Coeur Vaiss 1990; 83(8): 1115-1118.
36. Sokolovic S, Sabanovic N, Mislimi F, et al. White coat hypertension in normotensive and hypertensive patients: different results by doctors and nurses. J Hypertens 2012; 30(e-∼Supplement A): e495.
37. Richardson JF, Robinson D. Variations in the measurement of blood pressure between doctors and nurses. An observational study. J R Coll Gen Pract 1971; 21(113): 698-704.
38. Bo M, Comba M, Canade' A, et al. Clinical implications of white-coat effect among patients attending at a lipid clinic. Atherosclerosis 2008; 197(2): 904-909.
39. Bo M, Massaia M, Merlo C, et al. White-coat effect among older patients with suspected cognitive impairment: prevalence and clinical implications. Int J Geriatr Psychiatry 2009; 24(5): 509-517.
40. Gill JM, Al Mamari A, Ferrell WR, et al. Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men. J Am Coll Cardiol 2004; 44(12): 2375-2382.
41. Culleton BF, McKay DW, Campbell NR. Performance of the automated BpTRU measurement device in the assessment of white-coat hypertension and white-coat effect. Blood Press Monit 2006; 11(1): 37-42.
42. Porchet M, Bussien JP, Waeber B, et al. Unpredictability of blood pressures recorded outside the clinic in the treated hypertensive patient. J Cardiovasc Pharmacol 1986; 8(2): 332-335.
43. Myers MG, Oh PI, Reeves RA, Joyner CD. Prevalence of white coat effect in treated hypertensive patients in the community. Am J Hypertens 1995; 8(6): 591-597.
44. Paul L, Jane B, Lucy B, et al. Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure. BMJ 2002; 325.
45. Pickering TG, James GD, Boddie C, et al. How common is white coat hypertension? JAMA 1988; 259(2): 225-228.
46. Egger M, Smith GD, Altman DG. Systematic reviews in health care: metaanalysis in context. 2nd edn. London: BMJ, 2001.
47. White WB, Baker LH. Episodic hypertension secondary to panic disorder. Arch Intern Med 1986; 146(6): 1129-1130.
48. Fahey T, Schroeder K, Ebrahim S, Glynn L. Interventions used to improve control of blood pressure in patients with hypertension. In: Cochrane Collaboration. The Cochrane Library. Issue 1. Oxford: Update Software, 2005.
49. Martinez MA, Garcia-Puig J, Martin JC, et al. Frequency and determinants of white coat hypertension in mild to moderate hypertension: a primary carebased study. Monitorizacion Ambulatoria de la Presion Arterial (MAPA)-Area 5 Working Group. Am J Hypertens 1999; 12(3): 251-259.
50. Lindbaek M, Sandvik E, Liodden K, et al. Predictors for the white coat effect in general practice patients with suspected and treated hypertension. Br J Gen Pract 2003; 53(495): 790-793.
51. Millar JA, Accioly JM. Measurement of blood pressure may be affected by an interaction between subject and observer based on gender. J Hum Hypertens 1996; 10(7): 449-453.
52. Grassi G, Seravalle G, Buzzi S, et al. Muscle and skin sympathetic nerve traffic during physician and nurse blood pressure measurement. J Hypertens 2013; 31(6): 1131-1135.
53. National Centre for Social Research, Department of Epidemiology and Public Health UMS. Health Survey for England: 2010. NHS Information Centre for Health and Social Care, 2012.
54. Thomas O, Day K, Martin U, et al. White coat hypertension in treated hypertensive patients and factors influencing it. J Hum Hypertens 2012; 26(10): 618.
55. Odgaard Jensen-J, Vist GE, Timmer A, et al. Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst Rev 2011; 4: MR000012. DOI: 10.1002/14651858.MR000012.pub3.
56. Savovic J, Jones HE, Altman DG, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med 2012; 157(6): 429-438.
57. Mant J, McManus RJ. Measurement of blood pressure in primary care. BMJ 2011; 342: 343-344.
58. Veerman DP, de Blok K, Delemarre BJ, van Montfrans GA. Office, nurse, basal and ambulatory blood pressure as predictors of hypertensive target organ damage in male and female patients. J Hum Hypertens 1996; 10(1): 9-15.
59. Myers MG, Godwin M, Dawes M, et al. Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial. BMJ 2011; 342: d286.
60. Grossardt BR, Graves JW, Gullerud RE, et al. The occurrence of the alerting response is independent of the method of blood pressure measurement in hypertensive patients. Blood Press Monit 2006; 11(6): 321-327.
61. Vidt D, Lang RS, Seballos R, et al. Taking blood pressure: Too important to trust to humans? Cleveland Clin J Med 2010; 77(10): 683-688.
62. Sabater-Hernandez D, Sanchez-Villegas P, Garcia-Corp, et al. Predictors of the community pharmacy white-coat effect in treated hypertensive patients. The MEPAFAR study. Int J Clin Pharm 2011; 33(3): 582-589.
63. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005; 111(5): 697-716.
64. Head GA, Mihailidou AS, Duggan KA, et al. Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ 2010; 340: c1104.
65. Feher M, Harris-St John K, Lant A. Blood pressure measurement by junior hospital doctors-a gap in medical education? Health Trends 1992; 24(2): 59-61.
66. National Institute for Health and Clinical Excellence. Hypertension: the clinical management of primary hypertension in adults, CG127. London: National Institute for Health and Clinical Excellence, 2011.
67. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. J Hypertens 2013; 31: 1281-1357.
68. Parati G, Omboni S, Staessen J, et al. Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the 'white-coat' effect. Syst-Eur investigators. J Hypertens 1998; 16(1): 23-29.
69. Little P, Barnett J, Barnsley L, et al. Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure. BMJ 2002; 325(7358): 254.